Patient demographics | Normal (N = 50 |n (%)|) | Carcinoma (N = 42 |n (%)|) |
---|---|---|
Sex | ||
 Male | 24 (48.0) | 28 (66.7) |
 Female | 26 (52.0) | 14 (33.3) |
Age (years) | ||
 Median (± StDev) | 55.5 (± 3.7) | 70.5 (± 10.5) |
Histological type | ||
 Adenocarcinoma | – | 31 (73.8) |
 Signet ring cell carcinoma | – | 1 (2.4) |
 Mucinous adenocarcinoma | – | 2 (4.8) |
 High-grade neuroendocrine carcinoma | – | 1 (2.4) |
 Unknown |  | 7 (16.6%) |
Differentiation grade | ||
 Poor | – | 6 (14.3) |
 Moderate/well | – | 25 (59.5) |
 Unknown | – | 11 (26.2) |
T-stage | ||
 Stage 1 | – | 0 (0.0) |
 Stage 2 | – | 7 (16.7) |
 Stage 3 | – | 24 (57.1) |
 Stage 4 | – | 10 (23.8) |
 Unknown | – | 1 (2.4) |
Location | ||
 Proximal | – | 14 (33.3) |
 Distal | – | 25 (59.5) |
 Unknown/other | – | 3 (7.2) |